FCM
NEO icon

Farallon Capital Management’s NeoGenomics NEO Stock Holding History

Farallon Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,000
Closed -$141K – 150
2026
Q1 		$141K Hold
19,000
– – ﹤0.01% 157
2025
Q4 		$223K Buy
+19,000
New +$205K ﹤0.01% 129
2021
Q4 		– Sell
-529,839
Closed -$25.6M – 310
2021
Q3 		$25.6M Buy
529,839
+109,839
+26% +$5.08M 0.12% 92
2021
Q2 		$19M Buy
+420,000
New +$18.6M 0.08% 104

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Farallon Capital Management's NEO Position: Q2 2026 in Review

Farallon Capital Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 19,000 shares — an estimated $141K sold.

Farallon Capital Management first reported a position in NEO in Q2 2021 and held it in 4 quarters. The position peaked at $25.6M in Q3 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Farallon Capital Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Farallon Capital Management sold 19,000 NeoGenomics shares in Q2 2026, an estimated $141K.
  • Farallon Capital Management first reported a position in NeoGenomics in Q2 2021 and held it in 4 quarters.
  • Farallon Capital Management's NeoGenomics position peaked at $25.6M in Q3 2021.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.